Company profile for Aqilion

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Aqilion is a Swedish life science company. We believe the best source of new treatments comes from identifying, shaping and strengthening early drug innovation. We seek ideas that could potentially both improve patient quality of life and streamline health care. Aqilion pursues and transforms ideas aimed at testing and refining science into clinical translation. The goal is to deliver clinical proof-of-concept and an interesti...
Aqilion is a Swedish life science company. We believe the best source of new treatments comes from identifying, shaping and strengthening early drug innovation. We seek ideas that could potentially both improve patient quality of life and streamline health care. Aqilion pursues and transforms ideas aimed at testing and refining science into clinical translation. The goal is to deliver clinical proof-of-concept and an interesting value proposition to attract partners for the final phases of clinical development and commercialization.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Sweden
Address
Address
Kullagatan 8 SE-252 20 Helsingborg
Telephone
Telephone
+46 (0)70 664 9477
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-10-16/positive-results-from-clinical-pharmacokinetic-study-for-the-eosinophilic-esophagitis-specific-formulation-with-the-drug-candidate-aq280

PHARMIWEB
16 Oct 2025

https://www.pharmiweb.com/press-release/2025-02-05/aqilion-resumes-development-of-its-tak1-program

PHARMAWEB
05 Feb 2025

https://www.pharmiweb.com/press-release/2024-12-17/aqilion-to-present-at-biotech-showcasetm-during-jp-morgan-week-in-san-fransisco

PHARMAWEB
17 Dec 2024

https://www.prnewswire.com/news-releases/aqilion-announces-pre-clinical-licensing-and-strategic-research-collaboration-agreement-with-merck-301748483.html

PR NEWSWIRE
16 Feb 2023

https://endpts.com/merck-hands-swedish-biotech-e10m-cash-to-develop-anti-inflammatory-drugs/

Katherine Lewin ENDPTS
16 Feb 2023

https://www.aqilion.com/en/aqilion-strengthens-the-companys-pipeline-through-the-acquisition-of-a-phase-1-ready-anti-inflammatory-program-from-leo-pharma/

AQILION
05 Dec 2021

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty